Compound Profiling

Pharmacology profiling has become an invaluable tool for lead compound selection, optimization and candidate prioritization. Analysis of profile data identifies off-target interactions that can help predict potential side-effects, efficacy and safety of compounds under development before they progress to the more costly stages of preclinical and clinical trials. CDAS offers many in vitro profile programs to fit your drug discovery & development needs.

CDAS also offers a comprehensive in vivo compound profiling program to assess the therapeutic efficacy of lead or optimized lead compounds by analyzing their effects on key physiological functions in animals, or possibly, by screening for potential side effects caused by the administration of such compound(s).